Edesa Biotech Inc (EDSA)
2.15
+0.04
(+1.90%)
USD |
NASDAQ |
Nov 22, 13:14
Edesa Biotech Enterprise Value: 4.811M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 4.811M |
| November 20, 2024 | 5.103M |
| November 19, 2024 | 5.071M |
| November 18, 2024 | 5.100M |
| November 15, 2024 | 4.779M |
| November 14, 2024 | 5.103M |
| November 13, 2024 | 5.103M |
| November 12, 2024 | 5.723M |
| November 11, 2024 | 5.526M |
| November 08, 2024 | 5.818M |
| November 07, 2024 | 6.337M |
| November 06, 2024 | 6.857M |
| November 05, 2024 | 6.662M |
| November 04, 2024 | 6.305M |
| November 01, 2024 | 8.351M |
| October 31, 2024 | 8.676M |
| October 30, 2024 | 9.000M |
| October 29, 2024 | 8.773M |
| October 28, 2024 | 9.000M |
| October 25, 2024 | 9.000M |
| October 24, 2024 | 8.709M |
| October 23, 2024 | 9.910M |
| October 22, 2024 | 10.17M |
| October 21, 2024 | 10.38M |
| October 18, 2024 | 11.14M |
| Date | Value |
|---|---|
| October 17, 2024 | 11.27M |
| October 16, 2024 | 11.18M |
| October 15, 2024 | 11.47M |
| October 14, 2024 | 11.92M |
| October 11, 2024 | 11.10M |
| October 10, 2024 | 11.21M |
| October 09, 2024 | 11.57M |
| October 08, 2024 | 11.92M |
| October 07, 2024 | 11.73M |
| October 04, 2024 | 11.79M |
| October 03, 2024 | 11.83M |
| October 02, 2024 | 13.16M |
| October 01, 2024 | 13.03M |
| September 30, 2024 | 12.41M |
| September 27, 2024 | 11.89M |
| September 26, 2024 | 12.02M |
| September 25, 2024 | 12.05M |
| September 24, 2024 | 12.12M |
| September 23, 2024 | 12.35M |
| September 20, 2024 | 12.54M |
| September 19, 2024 | 12.09M |
| September 18, 2024 | 11.66M |
| September 17, 2024 | 11.81M |
| September 16, 2024 | 11.64M |
| September 13, 2024 | 12.15M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.474M
Minimum
Nov 13 2023
149.96M
Maximum
Sep 20 2021
31.04M
Average
17.82M
Median
Enterprise Value Benchmarks
| Aurinia Pharmaceuticals Inc | 906.94M |
| Lexaria Bioscience Corp | 25.27M |
| Xenon Pharmaceuticals Inc | 2.380B |
| ESSA Pharma Inc | -52.60M |
| ImmunoPrecise Antibodies Ltd | 8.777M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.668M |
| Total Expenses (Quarterly) | 1.696M |
| EPS Diluted (Quarterly) | -0.52 |
| Earnings Yield | -102.3% |
| Normalized Earnings Yield | -240.94 |